November 30, 2020 by Chain Drug Review
CVS Health, Evercore ISI 3rd Annual Global HealthCONx Conference, Karen Lynch, Larry Merlo
Leading Headlines, Pharmacy
WOONSOCKET, R.I.— CVS Health announced on Monday that Larry Merlo, president and chief executive officer; and Eva Boratto, executive vice president and chief financial officer; and Karen Lynch, executive vice president and president of Aetna will be participating in a fireside chat with investors at the Evercore ISI 3rd Annual Global HealthCONx Conference on December
November 11, 2020 by Chain Drug Review
CVS Health, Daniel Finke, Karen Lynch
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced on Wednesday that Daniel Finke has been named executive vice president, CVS Health and president, Health Care Benefits Segment (HCB) effective February 1, 2021. Finke will succeed Karen Lynch, who will become president and CEO of CVS Health in February. HCB provides solutions to employers and government businesses, serving more
November 6, 2020 by Chain Drug Review
CVS Health, David Dorman, Karen Lynch, Larry Merlo
Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health’s board of directors announced on Friday that Larry Merlo, who has served as CEO of CVS Health for a decade, is stepping down from his role next year and Karen Lynch, currently executive vice president, CVS Health and president, Aetna, will become the company’s next president and chief executive officer,
June 25, 2020 by Chain Drug Review
Aetna, CVS Health, Karen Lynch, U.S. Department of Health and Human Services finalized a rule that reduces anti-discrimination protections in health care for transgender people
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Last week, the U.S. Department of Health and Human Services finalized a rule that reduces anti-discrimination protections in health care for transgender people. The rule changed the previous definition for covered health care entities of “[discrimination] on the basis of sex” so that the definition no longer includes gender identity. CVS Health
March 25, 2020 by Chain Drug Review
Aetna, COVID-19, CVS Health, Karen Lynch
Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health announced Wednesday it is waiving cost-sharing and co-pays for inpatient hospital admissions related to COVID-19 for Aetna’s commercially insured members, part of several additional steps to help members access the care that they need during the COVID-19 pandemic. These announcements build on previous efforts focused on eliminating out-of-pocket costs and
February 11, 2020 by Chain Drug Review
CVS Health, Karen Lynch
Business, Leading Headlines, Retail News
WOONSOCKET, R.I. — To help provide support to underserved populations across the country, CVS Health invested $67 million in affordable housing in 2019. The investments helped to create more than 2,200 affordable homes with supportive services for individuals and families across 24 cities in six states. CVS Health’s investments in affordable housing – as well
December 31, 2019 by Chain Drug Review
CVS Health, Eva Boratto, J.P. Morgan Healthcare Conference, Karen Lynch, Larry Merlo
Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health announced Tuesday that Larry Merlo, president and chief executive officer, Eva Boratto, executive vice president and chief financial officer, and Karen Lynch, executive vice president and president of Aetna will be speaking to investors at the J.P. Morgan Healthcare Conference on January 14, 2020, at approximately 10:00 a.m. PT.
December 2, 2019 by Chain Drug Review
Centene Corp., CVS Health, IlliniCare Health Plan, Karen Lynch
Business, Leading Headlines, Pharmacy, Retail News
ST. LOUIS — Centene Corp. and CVS Health announced Monday that, in connection with the previously announced merger agreement between Centene and WellCare Health Plans, Centene has entered into a definitive agreement under which CVS Health will acquire Centene’s Illinois health plan subsidiary, IlliniCare Health Plan. The transaction entails the sale of Centene’s Medicaid and
July 29, 2019 by Chain Drug Review
Aetna, CVS Health, Dr. Alan Lotvin, HealthHUB, Karen Lynch, Path to Better Health Study by CVS Health
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — Millennials may be the first digital natives, but that love of technology could also be harming their health, according to the Path to Better Health Study by CVS Health. The study, now in its second year, explores consumer health goals and asks providers what they need to help patients reach those goals.
July 24, 2019 by Chain Drug Review
Building Healthier Communities initiative, CVS Health, Karen Lynch, Unite Us
Leading Headlines, Pharmacy
WOONSOCKET, R.I. — Approximately 60% of a person’s life expectancy is influenced by their everyday activities outside of the doctor’s office our individual behaviors, as well as social and environmental factors. To address this issue and help people improve their health outside of a clinical setting, CVS Health has announced the first in a series
June 6, 2018 by Chain Drug Review
Aetna, CVS Health, CVS Health-Aetna, David Denton, Dr. Alan M. Lotvin, Dr. Harold Paz, Dr. Troyen Brennan, Jon Roberts, Jr., Karen Lynch, Larry Merlo, Lisa Bisaccia, Mark Bertolini, Meg McCarthy, Richard di Benedetto, Rick Jelinek, Shawn Guertin, Steven Kelmar, Thomas Moriarty, Thomas Sabatino
Business, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has announced the management team that, following the close of the Aetna acquisition, will lead the combined company into the future. Aetna will operate as a stand-alone business unit within the CVS Health enterprise following the close and will be led by members of its current management team. In addition,